Case Study

Agora

An interactive platform to visually explore curated genomic analyses of Alzheimer's Disease

Allowing researchers to share and explore curated genomic analyses of AD.

The analyses accessible through Agora represent the culmination of over five years of research from the dozens of scientists that are part of the NIH-led Accelerating Medicines Partnership – Alzheimer’s Disease (AMP-AD) Target Discovery and Preclinical Validation Project.

The analyses accessible through Agora represent the culmination of over five years of research from the dozens of scientists that are part of the NIH-led Accelerating Medicines Partnership – Alzheimer’s Disease (AMP-AD) Target Discovery and Preclinical Validation Project.

"It is enabling precision medicine and facilitating the principles of open science and rapid dissemination of new targets with more shots on goal for AD."

Eliezer Masliah, M.D.

Director of the Division of Neuroscience at NIA


slider image

Feature 1

Description here. Description here. Description here. Description here. Description here. Description here.

slider image

Feature 2

Description here. Description here. Description here. Description here. Description here. Description here.

slider image

Feature 3

Description here. Description here. Description here. Description here. Description here. Description here.

slider image

Feature 4

Description here. Description here. Description here. Description here. Description here. Description here.